1.
EJHaem
; 5(2): 403-407, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38633116
RESUMO
Myeloperoxidase (MPO) is the most specific marker of the myeloid lineage, essential for diagnosing acute myeloid leukemia and mixed phenotype acute leukemia with myeloid components. In this regard, we present a unique case of B-acute lymphoblastic leukemia (B-ALL) with isolated MPO expression in bone marrow blasts detected by flow cytometry and immunohistochemistry, while peripheral blood blasts were negative for MPO expression. In this report, our discussion encompasses diagnostic pitfalls from a laboratory testing perspective in similar cases and includes a literature review. Furthermore, we emphasize the necessity of conducting a comprehensive analysis for the accurate diagnosis of MPO-positive B-ALL cases.
2.
Pathology
; 56(1): 115-118, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37573163
Assuntos
Doença de Hodgkin , Linfoma Difuso de Grandes Células B , Humanos , Doença de Hodgkin/diagnóstico , Doença de Hodgkin/genética , Doença de Hodgkin/patologia , Linfoma Difuso de Grandes Células B/diagnóstico , Linfoma Difuso de Grandes Células B/genética , Linfoma Difuso de Grandes Células B/patologia , Proteínas Proto-Oncogênicas c-bcl-2/genética , Rearranjo Gênico , Proteínas Proto-Oncogênicas c-myc/genética
3.
Int J Lab Hematol
; 45(3): e64-e67, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36537151
4.
Leuk Lymphoma
; 63(14): 3480-3483, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36154351